April 6, 2026 · Form 4 insider transaction
Baynes Roy D. bought 10,000 shares of Travere Therapeutics, Inc. at $26.52 per share, a transaction worth $265.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.